The factory was launched on Monday during a ceremony in the northern province of Alborz attended by Health Minister Seyed Hassan Qazizadeh Hashemi.
The pharmaceutical factory, which has 9 production lines manufacturing anticancer drugs, was established by the Actoverco pharmaceutical company with an investment of 100 million euros.
As the US sanctions against Iran have made it difficult for the people of the country to have access to some medications such as anticancer drugs, the company is providing a wide range of such medicines for patients.
Iranian experts have in recent years made great headways in using modern medical technology to cure a broad range of diseases inside the country, making Iran a top destination for medical tourism.
Back in 2015, Iran unveiled a rare drug named “Sitagliptin” that treats diabetes type 2 and has been produced by the country’s medical experts under the trade name “Ziptin”.
Previously, a German company had a monopoly on the drug, but Iran broke the monopoly by launching the production line of the medicine.